MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Chronic levodopa treatment accelerates the disorders of circadian rhythm in 6-OHDA induced Parkinson’s disease model

    S. Li, Y. Wang, W. Liu, D. Lv, C. Liu (Suzhou, People's Republic of China)

    Objective: We aimed to study the effect of levodopa on circadian rhythms in 6-OHDA lesioned rats, and to clarify whether the disturbance of the circadian…
  • 2016 International Congress

    Influence of motor manifestation and onset’s side on the spectrum of non-motor symptoms in patients with Parkinson’s disease

    M.A. Nikitina, I.A. Zhukova, V.M. Alifirova, N.G. Zhukova, O.P. Izhboldina, J.S. Mironova, M.A. Titova, N.G. Brazovskaya (Tomsk, Russia)

    Objective: To analyze Parkinson's disease (PD) motor manifestation and onset's side influence on the spectrum of non-motor symptoms (NMS). Background: Possibly the onset's side and…
  • 2016 International Congress

    Unusual motor and non-motor symptoms and signs in the early stage of Parkinson´s disease

    H.A.G. Teive, D.C. Bertucci, R.P. Munhoz (Curitiba, Brazil)

    Objective: To present unusual motor and non-motor symptoms and signs in the early stage of Parkinson´s disease. Background: Patients with Parkinson´s disease (PD) may present…
  • 2016 International Congress

    The combined effect of REM sleep behavior disorder and hyposmia on cognition and motor phenotype in Parkinson’s disease

    S.B. Koh, S.H. Kang, H.M. Lee, W.K. Seo, J.H. Kim (Seoul, Korea)

    Objective: We investigated the relationship between olfactory impairment, REM sleep behavior disorders (RBD), initial cognitive performance and motor phenotype in Parkinson's disease (PD). Background: Olfactory…
  • 2016 International Congress

    Hypothalamic volume loss is associated with reduced melatonin output in Parkinson’s disease

    D.P. Breen, C. Nombela, R. Vuono, P.S. Jones, K. Fisher, D.J. Burn, D.J. Brooks, A.B. Reddy, J.B. Rowe, R.A. Barker (Cambridge, United Kingdom)

    Objective: Our aim was to compare hypothalamic volumes in PD patients with matched controls, and determine whether volume loss correlated with reduced melatonin output in…
  • 2016 International Congress

    Premotor symptoms as prognostic indicators of Parkinson’s disease: A nationwide population-based and case-control study

    M.H. Chang (Taichung, Taiwan)

    Objective: To evaluate the association between the premotor symptoms and the prognosis of Parkinson's disease (PD) by utilizing Taiwan National Health Insurance Research Database. Background:…
  • 2016 International Congress

    Pulmonary dysfunction in Parkinson’s disease: A feature of early disease?

    G. Baille, T. Perez, D. Devos, L. Defebvre, C. Moreau (Lille, France)

    Objective: To characterize the abnormalities in pulmonary function tests (PFT) in early-diagnosed PD patients and to assess their prognostic features 2 years after. Background: Pulmonary…
  • 2016 International Congress

    Could smell test differ from scans without evidence of dopaminergic deficit and Parkinson’s disease?

    S.J. Kang, J.Y. Ahn, H.T. Kim (Seoul, Korea)

    Objective: To investigate the differences and similarities between SWEDD patients and PD patients using smell test. Background: The concept of SWEDD(scans without evidence of dopaminergic…
  • 2016 International Congress

    Depression and anxiety in Parkinson’s disease with rapid eye movement sleep behavior disorder

    Y. Saitoh, Y. Mukai, T. Sakamoto, M. Murata (Tokyo, Japan)

    Objective: To investigate whether rapid eye movement sleep behavior disorder (RBD) is associated with depression or anxiety in patients with Parkinson's disease (PD). Background: RBD…
  • 2016 International Congress

    The heterogeneity of fatigue in different stages of Parkinson’s disease

    M.R. Nodel, N.N. Yakhno (Moscow, Russia)

    Objective: To identify factors associated with fatigue in different stages of PD. Background: Fatigue is an important contributor to poor quality of life. However, it…
  • « Previous Page
  • 1
  • …
  • 1764
  • 1765
  • 1766
  • 1767
  • 1768
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley